Dr. Kay Yoon-Flannery Appointed Chief of Women's Oncology at AtlantiCare Cancer Care Institute

AtlantiCare Welcomes Dr. Kay Yoon-Flannery as Chief of Women's Oncology

Recently, AtlantiCare, the leading health system in southern New Jersey, made headlines with the appointment of renowned breast surgical oncologist Dr. Kay Yoon-Flannery as the Chief of Women's Oncology at their Cancer Care Institute. Known for her expertise and compassionate approach, Dr. Yoon-Flannery is set to spearhead the expansion of their comprehensive Women's Oncology Program, bringing together resources for breast, gynecologic, and genetic cancer services.

In her new role, Dr. Yoon-Flannery aims to create a more integrated healthcare experience for women, ensuring they have a seamless journey through prevention, diagnosis, and treatment. She emphasized, "This is a tremendous opportunity to unify breast, gynecologic, and genetic cancer services under one umbrella, making them easier to access and navigate." It is clear from her statement that her goal is not just to treat patients but to support them throughout their entire journey.

The emphasis on holistic care is not new for AtlantiCare, which has long valued women's cancer care as a critical part of their services. Their established breast and gynecologic oncology programs have been foundational in connecting patients to the care they need. Dr. Yoon-Flannery's focus will enhance these efforts, especially in areas of access and equity, making sure that women have the support and resources necessary at every stage, from early detection to recovery.

Dr. Joseph V. Lombardi, Chief Physician Executive at AtlantiCare, praised Dr. Yoon-Flannery, recognizing her as a visionary in women's healthcare. He stated, "Her appointment signifies a transformative moment for how we will deliver cancer care to women in South Jersey, ensuring that they receive not only exceptional surgical care but also empathy and innovation".

Beyond her leadership role, Dr. Yoon-Flannery will continue to practice, reflecting her commitment to staying connected with patients while she develops programs that enhance care coordination, strengthen team collaboration, and improve access for women across the region. Her reputation for excellence includes pioneering drain-free breast surgery and innovative surgical techniques like nipple-sparing mastectomy and hidden-scar approaches.

Patients often face overwhelming challenges when dealing with cancer, and Dr. Yoon-Flannery aims to be a steady presence in their journey. She said, "When women arrive for breast care, it often sets off a series of events much larger than they anticipate. I want them to know that they are not alone and that my team and I are here to support them in every way possible."

Along with the advanced cancer treatment options at AtlantiCare, the institute is connected to the Cleveland Clinic Cancer Institute, providing patients with access to cutting-edge research, clinical trials, and second opinions from top cancer experts. This affiliation greatly enhances the care offerings available to patients in South Jersey.

For women seeking guidance and support regarding cancer care, the AtlantiCare Cancer Care Institute offers direct access to health navigators at 609-677-7797. Dr. Yoon-Flannery's vision is one of a seamless network of support, easing the burdens on women facing cancer and empowering them throughout their journeys.

AtlantiCare is a leading healthcare provider in New Jersey, known for its commitment to innovative, community-centered care. With over 6,500 team members and more than 110 locations, AtlantiCare is dedicated to meeting the healthcare needs of southern New Jersey's diverse population. To learn more about Dr. Kay Yoon-Flannery and the AtlantiCare Cancer Care Institute's offerings, visit the official website at AtlantiCare.org.